Epidemiology of Parkinson's Disease: A Population-Based Study in Primary Care in Italy

Neuroepidemiology

Volumn 47, Issue 1, 2016, Pages 38-45

  Pupillo, Elisabetta ^a   Cricelli, Claudio ^b   Mazzoleni, Francesco ^b   Cricelli, Iacopo ^b   Pasqua, Alessandro ^b   Pecchioli, Serena ^b   Lapi, Francesco ^b   Beghi, Ettore ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b Health Search   (Italy)

Author keywords

Comorbidity; Incidence; Parkinson; Prevalence; Primary care

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; COMORBIDITY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; HYPERSOMNIA; ITALY; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POPULATION RESEARCH; PREVALENCE; RESTLESS LEGS SYNDROME; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; VERY ELDERLY; ADOLESCENT; FACTUAL DATABASE; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; PARKINSON DISEASE; YOUNG ADULT;

EID: 84981485026     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000448402     Document Type: Article

References (48)

1. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J: Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol 2011;26(suppl 1):S1-S58.
2. de Lau LM, Breteler MM: Epidemiology of Parkinson's disease. Lancet Neurol 2006;5:525-535.
3. Pringsheim T, Jette N, Frolkis A, Steeves TD: The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord 2014;29:1583-1590.
4. Casetta I, Granieri E, Govoni V, et al. Epidemiology of Parkinson's disease in Italy. A descriptive survey in the U.S.L. of Cento, province of Ferrara, Emilia-Romagna. Acta Neurol (Napoli) 1990;12:284-291.
5. Morgante L, Rocca WA, Di Rosa AE, et al. Prevalence of Parkinson's disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. The Sicilian neuro-epidemiologic study (SNES) group. Neurology 1992;42:1901-1907.
6. Beghi E, Monticelli ML, Sessa A, Simone P: The prevalence of parkinsonism in Italy: an epidemiological survey of the disease in general practice. The Italian general practitioner study group (IGPSG). Mov Disord 1994;9:403-408.
7. Chiò A, Magnani C, Schiffer D: Prevalence of Parkinson's disease in Northwestern Italy: comparison of tracer methodology and clinical ascertainment of cases. Mov Disord 1998;13:400-405.
8. de Rijk MC, Launer LJ, Berger K, et al. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology 2000;54(11 suppl 5):S21-S23.
9. Granieri E, Carreras M, Casetta I, et al. Parkinson's disease in Ferrara, Italy, 1967 through 1987. Arch Neurol 1991;48:854-857.
10. Baldereschi M, Di Carlo A, Rocca WA, et al. Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA working group. Italian longitudinal study on aging. Neurology 2000;55:1358-1363.
11. Csoti I, Jost WH, Reichmann H: Parkinosn's disease between internal medicine and neurology. J Neural Transm (Vienna) 2016;123:3-17.
12. Istituto Centrale di Statistica: Classificazione Delle Malattie, Traumatismi e Cause di Morte, IX Revisione-1975. Roma, Luglio, 1984.
13. Cricelli C, Mazzaglia G, Samani F, et al. Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases. J Public Health Med 2003;25:254-257.
14. Filippi A, Vanuzzo D, Bignamini AA, Mazzaglia G, Cricelli C, Catapano AL: The database of Italian general practitioners allows a reliable determination of the prevalence of myocardial infarction. Ital Heart J 2005;6:311-314.
15. Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
17. Totaro R, Marini C, Pistoia F, Sacco S, Russo T, Carolei A: Prevalence of Parkinson's disease in the L'Aquila district, central Italy. Acta Neurol Scand 2005;112:24-28.
18. Kis B, Schrag A, Ben-Shlomo Y, et al. Novel three-stage ascertainment method: prevalence of PD and parkinsonism in South Tyrol, Italy. Neurology 2002;58:1820-1825.
19. Hao K, Di Narzo AF, Ho L, et al. Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes. Mol Aspects Med 2015;43-44:66-76.
20. Li JQ, Tan L, Wang HF, et al. Risk factors for predicting progression from mild cognitive impairment to Alzheimer's disease: a systematic review and meta-analysis of cohort studies. J Neurol Neurosurg Psychiatry 2016;87:476-484.
21. Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J: Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 2007;30:842-847.
22. Driver JA, Smith A, Buring JE, Gaziano JM, Kurth T, Logroscino G: Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 2008;31:2003-2005.
23. Becker C, Brobert GP, Johansson S, Jick SS, Meier CR: Diabetes in patients with idiopathic Parkinson's disease. Diabetes Care 2008;31:1808-1812.
24. D'Amelio M, Ragonese P, Callari G, et al. Diabetes preceding Parkinson's disease onset. A case-control study. Parkinsonism Relat Disord 2009;15:660-664.
25. Zoccolella S, Savarese M, Lamberti P, Manni R, Pacchetti C, Logroscino G: Sleep disorders and the natural history of Parkinson's disease: the contribution of epidemiological studies. Sleep Med Rev 2011;15:41-50.
26. Tandberg E, Larsen JP, Karlsen K: Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov Disord 1999;14:922-927.
27. Braga-Neto P, da Silva-Júnior FP, Sueli Monte F, de Bruin PF, de Bruin VM: Snoring and excessive daytime sleepiness in Parkinson's disease. J Neurol Sci 2004;217:41-45.
28. Wong JC, Schwarzschild MA, Ascherio A, Gao X: Restless legs syndrome: an early clinical feature of Parkinson disease in men. Sleep 2014;37:369-372.
29. Rijsman RM, Schoolderman LF, Rundervoort RS, Louter M: Restless legs syndrome in Parkinson's disease. Parkinsonism Relat Disord 2014;20(suppl 1):S5-S9.
30. Ondo WG, Vuong KD, Jankovic J: Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 2002;59:421-424.
31. Gómez-Esteban JC, Zarranz JJ, Tijero B, et al. Restless legs syndrome in Parkinson's disease. Mov Disord 2007;22:1912-1916.
32. Nomura T, Inoue Y, Miyake M, Yasui K, Nakashima K: Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson's disease. Mov Disord 2006;21:380-384.
33. Krishnan PR, Bhatia M, Behari M: Restless legs syndrome in Parkinson's disease: a case-controlled study. Mov Disord 2003;18:181-185.
34. Loo HV, Tan EK: Case-control study of restless legs syndrome and quality of sleep in Parkinson's disease. J Neurol Sci 2008;266:145-149.
35. Fereshtehnejad SM, Shafieesabet M, Shahidi GA, Delbari A, Lökk J: Restless legs syndrome in patients with Parkinson's disease: a comparative study on prevalence, clinical characteristics, quality of life and nutritional status. Acta Neurol Scand 2015;131:211-218.
36. Fasano A, Visanji NP, Liu LW, Lang AE, Pfeiffer RF: Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 2015;14:625-639.
37. Ross GW, Abbott RD, Petrovitch H, Tanner CM, White R: Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience. Parkinsonism Relat Disord 2012;18(suppl 1):S199-S202.
38. Makaroff L, Gunn A, Gervasoni C, Richy F: Gastrointestinal disorders in Parkinson's disease: prevalence and health outcomes in a US claims database. J Parkinsons Dis 2011;1:65-74.
39. Jain S, Goldstein DS: Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis. Neurobiol Dis 2012;46:572-580.
40. Noack C, Schroeder C, Heusser K, Lipp A: Cardiovascular effects of levodopa in Parkinson's disease. Parkinsonism Relat Disord 2014;20:815-818.
41. Perez-Lloret S, Rey MV, Crispo J, et al. Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients. Expert Opin Drug Saf 2014;13:351-360.
42. Buoli M, Caldiroli A, Altamura AC: Psychiatric conditions in Parkinson disease: a comparison with classical psychiatric disorders. J Geriatr Psychiatry Neurol 2016;29:72-91.
43. Noyce AJ, Bestwick JP, Silveira-Moriyama L, et al. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol 2012;72:893-901.
44. Bajaj A, Driver JA, Schernhammer ES: Parkinson's disease and cancer risk: a systematic review and meta-analysis. Cancer Causes Control 2010;21:697-707.
45. Liu R, Gao X, Lu Y, Chen H: Meta-analysis of the relationship between Parkinson disease and melanoma. Neurology 2011;76:2002-2009.
46. Gorell JM, Johnson CC, Rybicki BA: Parkinson's disease and its comorbid disorders: an analysis of Michigan mortality data, 1970 to 1990. Neurology 1994;44:1865-1868.
47. Rizzo G, Copetti M, Arcuti S, Martino D, et al. Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology 2016;86:566-576.
48. Wermuth L, Lassen CF, Himmerslev L, Olsen J, Ritz B: Validation of hospital register-based diagnosis of Parkinson's disease. Dan Med J 2012;59:A4391.